Tuesday , 22 January 2019
Breaking News
Google Life Sciences and American Heart Association commit $50M to study heart disease

Google Life Sciences and American Heart Association commit $50M to study heart disease

Google Life Sciences and the American Heart Association (AHA) announced that they’re teaming together to fight heart disease. Both organizations have committed to donating $25 million each over the next five years to better understand and cure heart disease.

“With its devastating human impact on countless generations of families, cardiovascular disease, and in particular coronary heart disease remains the greatest and deadliest global health challenge we face today,” said AHA chief executive Nancy Brown in a statement. “By working together, AHA and Google Life Sciences will be able to serve as the catalyst for change and transformation in reducing the impact of coronary heart disease on people’s lives and alleviating this global burden.”

The $50 million investment will fund one research team tasked with developing “a richer, deeper understanding of cardiovascular disease.” Called the largest single research investment in the AHA’s history, the team will include investigators and will design a program to discover new causes and drivers of coronary heart disease. The AHA says this team will also have support from across clinical research, engineering, data analysis, strategic counsel, and more from within its Joint Leadership Group.

According to the AHA, cardiovascular diseases are the number one cause of death globally — 17 million people have died due to different heart ailments. Coronary heart disease specifically is responsible for 7 million deaths each year. What has confounded researchers and health professionals are the root causes.

Targeting heart disease is the latest foray of Google Life Sciences as it previously set its eye on developing new ways to treat and manage diabetes. Now with a look towards heart disease, Google shows that it’s aiming at all serious diseases including cancer and neurodegenerative conditions.

Google Life Sciences is a company that spun out from Google following the massive organization change that happened earlier this year. It formerly was a division of Google X and works on moonshot projects around making lives better. Included in its portfolio are contact lenses to monitor people’s glucose levels, a spoon to monitor tremors, a disease-detecting nanoparticle platform, and a health-tracking wristband.

In 2013, the organization hired former Genentech CEO Art Levinson to lead Calico, a company to study aging and associated diseases. In September, Google Life Sciences brought on board the former director of the National Institute of Mental Health Thomas Insel to help the company focus on mental illnesses. Each of its efforts seems to have also drawn support of partners within the medical field, such as pharmaceutical company Novartis and with drug company AbbVie.

Google’s innovative search technologies connect millions of people around the world with information every day. Founded in 1998 by Stanford Ph.D. students Larry Page and Sergey Brin, Google today is a top web property in all major glob… read more »

The American Heart Association is the nation’s oldest, largest voluntary organization devoted to fighting cardiovascular diseases and stroke. Founded by six cardiologists in 1924, our organization now includes more than 22.5 million … read more »

Powered by VBProfiles

Article Source

Share and Enjoy

Leave a Reply

Your email address will not be published. Required fields are marked *